Milanovic, M.S.; Kadijevich, D.M.; Stojanovich, L.; Milovanovic, B.; Djokovic, A.
A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections. Medicina 2022, 58, 76.
https://doi.org/10.3390/medicina58010076
AMA Style
Milanovic MS, Kadijevich DM, Stojanovich L, Milovanovic B, Djokovic A.
A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections. Medicina. 2022; 58(1):76.
https://doi.org/10.3390/medicina58010076
Chicago/Turabian Style
Milanovic, Milomir S., Djordje M. Kadijevich, Ljudmila Stojanovich, Branislav Milovanovic, and Aleksandra Djokovic.
2022. "A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections" Medicina 58, no. 1: 76.
https://doi.org/10.3390/medicina58010076
APA Style
Milanovic, M. S., Kadijevich, D. M., Stojanovich, L., Milovanovic, B., & Djokovic, A.
(2022). A Lower Level of Post-Vaccinal Antibody Titer against Influenza Virus A H1N1 May Protect Patients with Autoimmune Rheumatic Diseases from Respiratory Viral Infections. Medicina, 58(1), 76.
https://doi.org/10.3390/medicina58010076